Drug: INFLIXIMAB, RECOMBINANT Injury: Psoriasis Quarter: 2016Q3
Total Records: 4 Number of Pages: 1
Event ID | DRUGNAME | PT | Drug Manufacturer | Patient Age | Sex | Weight | Date (YYYYMMDD) | Country |
---|---|---|---|---|---|---|---|---|
123818183 | INFLIXIMAB, RECOMBINANT | Psoriasis | JANSSEN | 8.00 YR | M | 0 | 20160705 | US |
125215222 | INFLIXIMAB, RECOMBINANT | Psoriasis | JANSSEN | 0.00 | 0 | 20160813 | CA | |
125532791 | INFLIXIMAB, RECOMBINANT | Psoriasis | JANSSEN | 0.00 | 0 | 20160713 | CA | |
127596902 | INFLIXIMAB, RECOMBINANT | Psoriasis | JANSSEN | 0.00 | M | 71 KG | 20160926 | AU |
Total Records: 4 Number of Pages: 1